×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [6]
THE STATE KEY LA... [6]
Faculty of Healt... [5]
Authors
LU JINJIAN [3]
CHEN XIUPING [1]
HU YUANJIA [1]
LIN LIGEN [1]
CHEN QIANG [1]
HANMING SHEN [1]
More...
Document Type
Journal article [8]
Review article [1]
Date Issued
2024 [5]
2022 [2]
2021 [2]
Language
英語English [9]
Source Publication
Acta Pharmacolog... [6]
ACTA PHARMACOLOG... [3]
Indexed By
SCIE [9]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-9 of 9
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Author Ascending
Author Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Title Ascending
Title Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis
Journal article
Li, Yue Kang, Ge, Fu Jing, Liu, Xiang Ning, Zeng, Chen Ming, Qian, Mei Jia, Li, Yong Hao, Zheng, Ming Ming, Qu, Jing Jing, Fang, Liang Jie, Lu, Jin Jian, Yang, Bo, He, Qiao Jun, Zhou, Jian Ya, Zhu, Hong. Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis[J]. Acta Pharmacologica Sinica, 2024.
Authors:
Li, Yue Kang
;
Ge, Fu Jing
;
Liu, Xiang Ning
;
Zeng, Chen Ming
;
Qian, Mei Jia
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
1
IF:
6.9
/
7.6
|
Submit date:2024/12/26
Acquired Resistance
Cftr
Ivacaftor
Nsclc
Osimertinib
SP600125, a selective JNK inhibitor, is a potent inhibitor of NAD(P)H: quinone oxidoreductase 1 (NQO1)
Journal article
Zhong, Bing Ling, Zhang, Yi Fei, Zheng, Hao Yi, Chen, Qiang, Lu, Hua Dong, Chen, Xiu Ping. SP600125, a selective JNK inhibitor, is a potent inhibitor of NAD(P)H: quinone oxidoreductase 1 (NQO1)[J]. Acta Pharmacologica Sinica, 2024.
Authors:
Zhong, Bing Ling
;
Zhang, Yi Fei
;
Zheng, Hao Yi
;
Chen, Qiang
;
Lu, Hua Dong
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
1
IF:
6.9
/
7.6
|
Submit date:2024/12/05
Jnk
Nqo1
Sp600125
E3 ubiquitin ligase UBR5 modulates circadian rhythm by facilitating the ubiquitination and degradation of the key clock transcription factor BMAL1
Journal article
Duan, Chunyan, Li, Yue, Zhi, Haoyu, Tian, Yao, Huang, Zhengyun, Chen, Suping, Zhang, Yang, Liu, Qing, Zhou, Liang, Jiang, Xiaogang, Ullah, Kifayat, Guo, Qing, Liu, Zhaohui, Xu, Ying, Han, Junhai, Hou, Jiajie, O’Connor, Darran P., Xu, Guo qiang. E3 ubiquitin ligase UBR5 modulates circadian rhythm by facilitating the ubiquitination and degradation of the key clock transcription factor BMAL1[J]. ACTA PHARMACOLOGICA SINICA, 2024, 45(9), 1793-1808.
Authors:
Duan, Chunyan
;
Li, Yue
;
Zhi, Haoyu
;
Tian, Yao
;
Huang, Zhengyun
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
1
IF:
6.9
/
7.6
|
Submit date:2024/06/05
Bmal1
Circadian Rhythm
Proteomics
Transcriptional Activity
Ubiquitination
Ubr5
Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma
Journal article
Zhang, Qi Yi, Ding, Wen, Mo, Jian Shan, Ou-yang, Shu Min, Lin, Zi You, Peng, Ke Ren, Liu, Guo Pin, Lu, Jin Jian, Yue, Pei Bin, Lei, Jin Ping, Wang, Yan Dong, Zhang, Xiao Lei. Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma[J]. ACTA PHARMACOLOGICA SINICA, 2024.
Authors:
Zhang, Qi Yi
;
Ding, Wen
;
Mo, Jian Shan
;
Ou-yang, Shu Min
;
Lin, Zi You
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
7
IF:
6.9
/
7.6
|
Submit date:2024/05/16
Acquired Sorafenib-resistance
Antisense Oligonucleotide
Hepatocellular Carcinoma
Stat3
Paraptosis: a non-classical paradigm of cell death for cancer therapy
Review article
2024
Authors:
Xu, Chun cao
;
Lin, Yi fan
;
Huang, Mu yang
;
Zhang, Xiao lei
;
Wang, Pei
; et al.
Favorite
|
TC[WOS]:
21
TC[Scopus]:
19
IF:
6.9
/
7.6
|
Submit date:2024/02/22
Cancer Therapy
Endoplasmic Reticulum
Er Stress
Mitochondria
Paraptosis
14-Deoxygarcinol improves insulin sensitivity in high-fat diet-induced obese mice via mitigating NF-κB/Sirtuin 2-NLRP3-mediated adipose tissue remodeling
Journal article
Jia-li Chen, Zhe-ling Feng, Fei Zhou, Ruo-han Lou, Cheng Peng, Yang Ye, Li-gen Lin. 14-Deoxygarcinol improves insulin sensitivity in high-fat diet-induced obese mice via mitigating NF-κB/Sirtuin 2-NLRP3-mediated adipose tissue remodeling[J]. Acta Pharmacologica Sinica, 2022, 44, 434–445.
Authors:
Jia-li Chen
;
Zhe-ling Feng
;
Fei Zhou
;
Ruo-han Lou
;
Cheng Peng
; et al.
Favorite
|
TC[WOS]:
11
TC[Scopus]:
12
IF:
6.9
/
7.6
|
Submit date:2023/01/30
14-deoxygarcinol
Adipose Tissue Inflammation
Insulin Resistance
Interleukin-1β
Nlrp3 Inflammasome
Sirtuin 2
Novel treatment for refractory rheumatoid arthritis with total glucosides of paeony and nobiletin codelivered in a self-nanoemulsifying drug delivery system
Journal article
Qu, Biao, Wang, Xiao lin, Zheng, De chong, Mai, Chu tian, Liu, Zhong qiu, Zhou, Hua, Xie, Ying. Novel treatment for refractory rheumatoid arthritis with total glucosides of paeony and nobiletin codelivered in a self-nanoemulsifying drug delivery system[J]. Acta Pharmacologica Sinica, 2022, 43(8), 2094-2108.
Authors:
Qu, Biao
;
Wang, Xiao lin
;
Zheng, De chong
;
Mai, Chu tian
;
Liu, Zhong qiu
; et al.
Favorite
|
TC[WOS]:
12
TC[Scopus]:
10
IF:
6.9
/
7.6
|
Submit date:2023/01/30
Nobiletin
P-glycoprotein
Refractory Rheumatoid Arthritis
Self-nanoemulsifying Drug Delivery Systems
Total Glucosides Of Paeony
The challenges and opportunities of traditional Chinese medicines against COVID-19: a way out from a network perspective
Journal article
Zuo, Hua li, Lin, Yang Chi Dung, Huang, Hsi Yuan, Wang, Xu, Tang, Yun, Hu, Yuan jia, Kong, Xiang jun, Chen, Qian jun, Zhang, Yu zhu, Hong, Hsiao Chin, Li, Jing, Hu, Si yao, Huang, Hsien Da. The challenges and opportunities of traditional Chinese medicines against COVID-19: a way out from a network perspective[J]. ACTA PHARMACOLOGICA SINICA, 2021, 42(6), 845-847.
Authors:
Zuo, Hua li
;
Lin, Yang Chi Dung
;
Huang, Hsi Yuan
;
Wang, Xu
;
Tang, Yun
; et al.
Favorite
|
TC[WOS]:
7
TC[Scopus]:
8
IF:
6.9
/
7.6
|
Submit date:2021/12/08
Garciesculenxanthone B induces PINK1-Parkin-mediated mitophagy and prevents ischemia-reperfusion brain injury in mice
Journal article
Wu,Man, Lu,Guang, Lao,Yuan zhi, Zhang,Hong, Zheng,Dan, Zheng,Zhao qing, Yi,Juan, Xiang,Qian, Wang,Li ming, Tan,Hong sheng, Zhou,Hua, Shen,Han ming, Xu,Hong xi. Garciesculenxanthone B induces PINK1-Parkin-mediated mitophagy and prevents ischemia-reperfusion brain injury in mice[J]. Acta Pharmacologica Sinica, 2021, 42(2), 199-208.
Authors:
Wu,Man
;
Lu,Guang
;
Lao,Yuan zhi
;
Zhang,Hong
;
Zheng,Dan
; et al.
Favorite
|
TC[WOS]:
46
TC[Scopus]:
48
IF:
6.9
/
7.6
|
Submit date:2021/03/02
Garciesculenxanthone b
Ischemia-reperfusion Injury
Mitophagy
Parkin
Pink1